Alnylam Pharmaceuticals Inc Earnings

Healthcare · Biotechnology
Beat Rate
66.7%
4/6 quarters
Last EPS
$1.21
Estimate
$1.59
Surprise
-23.70%
Last Report
2026-06

Upcoming Reports

Report Date Period EPS Est. Revenue Est.
Wed, Oct 28, 2026 2026-09 $1.78 $1.5B

Earnings History

Period Report Date EPS Est. EPS Actual Surprise Result
2026-06 Jul 29, 2026 $1.59 $1.21 -23.70% Miss
2026-03 · $0.98 $1.51 +53.85% Beat
2025-12 · $1.15 $0.82 -28.48% Miss
2025-09 · $0.76 $2.11 +177.16% Beat
2025-06 · $-0.73 $-0.51 +30.60% Beat
2025-03 · $-1.03 $-0.44 +57.21% Beat

EPS Track Record

66.7% Beat Rate
Beats 4
Misses 2
Total reported 6